CRLNYSE

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Healthcare·Healthcare·Wilmington, MA, United States

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): 49 pipeline candidates · ~11 mo cash runway · 1 clinical trial. Updated within the last hour.

6.8/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway3.1

11.0 months

Financial Health7.4

D/E 1.61 · 2% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

49 candidates

Catalyst MomentumN/A

N/A

Insider Signal6.5

1 buy · 0 sells (180d)

A transparent, data-derived signal for CHARLES RIVER LABORATORIES INTERNATIONAL, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$8.8B

Cash

$198.2M

Quarterly Burn

$159.4M

Runway

11.0 mo

Revenue

$995.8M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~May 2027
Today~12 mo out
Catalyst within runway

Pipeline (49 candidates)

Showing 10 of 49 candidates. Sign up for full pipeline.

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

557

Total value held

$9.23B

HolderSharesValue
vanguard capital management llc6,404,408$1.10B
blackrock, inc.3,859,100$665.7M
fmr llc3,456,244$596.2M
vanguard portfolio management llc2,294,670$395.8M
harris associates l p2,153,296$371.4M
state street corp1,873,618$323.2M
dimensional fund advisors lp1,652,484$285.0M
wellington management group llp1,629,401$281.1M
ariel investments, llc1,444,183$249.1M
geode capital management, llc1,305,694$224.8M

Showing top 10 of 557 institutional holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

1 clinical trial·CEO: Ms. Birgit Girshick

Frequently asked questions

How many drug candidates are in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s pipeline?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) has 49 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. has approximately 11.0 months of cash runway.

What is CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s market capitalization?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s market capitalization is approximately $8.8B.

Who is the CEO of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.?

Ms. Birgit Girshick is the chief executive officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).

Get the full picture on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.